JP2013181034A5 - - Google Patents

Download PDF

Info

Publication number
JP2013181034A5
JP2013181034A5 JP2013107244A JP2013107244A JP2013181034A5 JP 2013181034 A5 JP2013181034 A5 JP 2013181034A5 JP 2013107244 A JP2013107244 A JP 2013107244A JP 2013107244 A JP2013107244 A JP 2013107244A JP 2013181034 A5 JP2013181034 A5 JP 2013181034A5
Authority
JP
Japan
Prior art keywords
seq
composition
antigenic peptide
molecule
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013107244A
Other languages
English (en)
Japanese (ja)
Other versions
JP5717210B2 (ja
JP2013181034A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013181034A publication Critical patent/JP2013181034A/ja
Publication of JP2013181034A5 publication Critical patent/JP2013181034A5/ja
Application granted granted Critical
Publication of JP5717210B2 publication Critical patent/JP5717210B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2013107244A 2002-03-05 2013-05-21 免疫化組成物およびアミロイド前駆体タンパク質のβ−セクレターゼ切断部位に対する免疫応答を誘発するための方法 Expired - Fee Related JP5717210B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36134402P 2002-03-05 2002-03-05
US60/361,344 2002-03-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010114047A Division JP2010248197A (ja) 2002-03-05 2010-05-18 免疫化組成物およびアミロイド前駆体タンパク質のβ−セクレターゼ切断部位に対する免疫応答を誘発するための方法

Publications (3)

Publication Number Publication Date
JP2013181034A JP2013181034A (ja) 2013-09-12
JP2013181034A5 true JP2013181034A5 (enExample) 2014-07-10
JP5717210B2 JP5717210B2 (ja) 2015-05-13

Family

ID=27805031

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003574670A Pending JP2005532276A (ja) 2002-03-05 2003-03-04 免疫化組成物およびアミロイド前駆体タンパク質のβ−セクレターゼ開裂部位に対する免疫応答を誘発する方法
JP2010114047A Pending JP2010248197A (ja) 2002-03-05 2010-05-18 免疫化組成物およびアミロイド前駆体タンパク質のβ−セクレターゼ切断部位に対する免疫応答を誘発するための方法
JP2013107244A Expired - Fee Related JP5717210B2 (ja) 2002-03-05 2013-05-21 免疫化組成物およびアミロイド前駆体タンパク質のβ−セクレターゼ切断部位に対する免疫応答を誘発するための方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2003574670A Pending JP2005532276A (ja) 2002-03-05 2003-03-04 免疫化組成物およびアミロイド前駆体タンパク質のβ−セクレターゼ開裂部位に対する免疫応答を誘発する方法
JP2010114047A Pending JP2010248197A (ja) 2002-03-05 2010-05-18 免疫化組成物およびアミロイド前駆体タンパク質のβ−セクレターゼ切断部位に対する免疫応答を誘発するための方法

Country Status (8)

Country Link
US (3) US7494655B2 (enExample)
EP (2) EP1480666B1 (enExample)
JP (3) JP2005532276A (enExample)
AU (1) AU2003225636A1 (enExample)
CA (1) CA2477675C (enExample)
ES (1) ES2392247T3 (enExample)
IL (3) IL163812A0 (enExample)
WO (1) WO2003076455A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1398019A1 (de) 2002-09-13 2004-03-17 Cognis France S.A. Verfahren zum Schutz und zur Modulation von Dermal Epidermal Junctions
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
WO2005033278A2 (en) * 2003-09-30 2005-04-14 Ludwig Institute For Cancer Research In vivo efficacy of ny-eso-1 plus iscom
AU2005297854A1 (en) * 2004-10-28 2006-05-04 Sanko Junyaku Co., Ltd. Method of examining Alzheimer's disease and diagnostic reagent
KR101451991B1 (ko) 2005-10-18 2014-10-22 스타파마 피티와이 리미티드 살미생물성 덴드리머 조성물 전달 시스템
HUE031341T2 (hu) 2005-10-25 2017-07-28 Starpharma Pty Ltd Ellenõrzött sztöchiometriájú makromolekuláris vegyületek
PT1954718E (pt) 2005-11-30 2014-12-16 Abbvie Inc Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos
KR20180058863A (ko) 2005-11-30 2018-06-01 애브비 인코포레이티드 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
JP5989294B2 (ja) * 2006-01-20 2016-09-07 スターファーマ・プロプライエタリー・リミテッドStarpharma Pty Ltd 修飾高分子
ES2558875T3 (es) 2006-03-22 2016-02-09 Starpharma Pty Limited Composición anticonceptiva
WO2008011503A2 (en) * 2006-07-21 2008-01-24 Ramot At Tel Aviv University Ltd. Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates
EP2052011B1 (en) 2006-08-11 2020-11-04 Starpharma Pty Limited Targeted polylysine dendrimer therapeutic agent
WO2008064401A1 (en) * 2006-11-28 2008-06-05 Alzhyme Pty Ltd Improved peptide composition
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
JP4920084B2 (ja) 2007-09-27 2012-04-18 株式会社ウイルス医科学研究所 ヘルペスウイルスの潜伏感染に関与する因子及びその利用
GB0720912D0 (en) 2007-10-25 2007-12-05 Univ Cardiff Monoclonal Anitbody for APP
KR101397554B1 (ko) * 2007-11-09 2014-05-21 재단법인서울대학교산학협력재단 치매(알츠하이머 병)의 진단, 예방, 치료제 및 이들의스크리닝 방법
UY31520A1 (es) 2007-12-11 2009-08-03 Proteinas de union a antigenos
WO2009124119A2 (en) * 2008-04-01 2009-10-08 The Trustes of Columbia University in the City of New York Phosphodiesterase inhibitors and uses thereof
WO2009155538A1 (en) * 2008-06-20 2009-12-23 Merck & Co., Inc. Compositions and methods of depleting amyloid-beta peptides from cerebrospinal fluid to treat alzheimer's disease
TW201438738A (zh) * 2008-09-16 2014-10-16 建南德克公司 治療進展型多發性硬化症之方法
SG171791A1 (en) * 2008-11-24 2011-07-28 Univ Ramot Method for treating parkinson' s disease using filamentous bacteriophage
EP2379076B1 (en) 2008-12-23 2014-11-12 The Trustees of Columbia University in the City of New York Phosphodiesterase inhibitors and uses thereof
WO2011031720A1 (en) * 2009-09-11 2011-03-17 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Bispecific nanobodies as a therapeutic for alzheimer's disease
MX336196B (es) 2010-04-15 2016-01-11 Abbvie Inc Proteinas de union a amiloide beta.
EP3533803B1 (en) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antibodies
US10067142B2 (en) 2014-06-27 2018-09-04 Japan Tobacco Inc. Method for diagnosing, treating, or preventing mood disorder
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN106349334A (zh) * 2015-07-15 2017-01-25 韩震 一种多肽化合物及其制备方法与应用
CN108431046A (zh) 2015-12-28 2018-08-21 日本烟草产业株式会社 诊断、治疗或预防心境障碍的方法
JP7368856B2 (ja) 2017-07-25 2023-10-25 トゥルーバインディング,インコーポレイテッド Tim-3とそのリガンドとの相互作用の遮断によるがん治療
CN120058944A (zh) 2019-01-30 2025-05-30 真和制药有限公司 抗gal3抗体及其用途
JP2023528797A (ja) 2020-05-26 2023-07-06 トゥルーバインディング,インコーポレイテッド ガレクチン-3を遮断することにより炎症性疾患を処置する方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376861A (en) 1976-06-23 1983-03-15 The Dow Chemical Company Method for preparing 2-alkenyl-2-oxazolines
US4289872A (en) 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4600535A (en) 1982-02-12 1986-07-15 The Dow Chemical Company Cyclic peptides
US4517122A (en) 1982-02-12 1985-05-14 The Dow Chemical Company Cyclic peptides
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4515920A (en) 1984-04-30 1985-05-07 The Rockefeller University Synthesis of peptides and proteins
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4599400A (en) 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
US5268164A (en) 1990-04-23 1993-12-07 Alkermes, Inc. Increasing blood-brain barrier permeability with permeabilizer peptides
ES2217250T3 (es) * 1990-06-15 2004-11-01 Scios Inc. Mamifero transgenico, no humano que muestra la patologia de formacion amiloides de la enfermedad de alzheimer.
US5222982A (en) 1991-02-11 1993-06-29 Ommaya Ayub K Spinal fluid driven artificial organ
US5441870A (en) * 1992-04-15 1995-08-15 Athena Neurosciences, Inc. Methods for monitoring cellular processing of β-amyloid precursor protein
US5580563A (en) 1992-05-01 1996-12-03 Tam; James P. Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
US5716614A (en) 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
US6221645B1 (en) 1995-06-07 2001-04-24 Elan Pharmaceuticals, Inc. β-secretase antibody
JPH11507538A (ja) 1995-06-07 1999-07-06 アテナ ニューロサイエンシズ インコーポレイティド β−セクレターゼ、β−セクレターゼに対する抗体、及びβ−セクレターゼ阻害を検出するためのアッセイ
US5744346A (en) 1995-06-07 1998-04-28 Athena Neurosciences, Inc. β-secretase
US5719867A (en) 1995-06-30 1998-02-17 Scientific-Atlanta, Inc. Plural telephony channel baseband signal demodulator for a broadband communications system
WO1998021589A1 (en) 1996-11-15 1998-05-22 The Trustees Of The University Of Pennsylvania Screening for modulators of amyloid processing
AU753688B2 (en) 1997-03-10 2002-10-24 Ottawa Civic Loeb Research Institute Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US6703015B1 (en) 1999-09-03 2004-03-09 Ramot At Tel-Aviv University Ltd. Filamentous bacteriophage displaying an β-amyloid epitope
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US6313268B1 (en) 1998-10-16 2001-11-06 Vivian Y. H. Hook Secretases related to Alzheimer's dementia
HK1044545A1 (zh) 1999-02-10 2002-10-25 Elan Pharmaceuticals, Inc. 贝他分泌酶组合物及其方法
WO2001014579A2 (en) * 1999-08-26 2001-03-01 Vion Pharmaceuticals, Inc. Compositions and methods for delivery of an agent using attenuated salmonella containing phage
US20040013647A1 (en) 1999-09-03 2004-01-22 Ramot At Tel-Aviv University Ltd. Methods and compositions for treating a plaque-forming disease
US20020052311A1 (en) 1999-09-03 2002-05-02 Beka Solomon Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders
US6919075B1 (en) 1999-09-03 2005-07-19 Ramot At Tel Aviv University Ltd. Bacteriophage displaying aβ epitopes and method of use
AU2001229592A1 (en) * 2000-01-21 2001-07-31 University Of Connecticut Health Center Vaccines against neurodegenerative disorders
EP1397380B1 (en) 2001-06-20 2006-12-27 Ramot at Tel Aviv University Ltd. Multiple antigenic peptide displaying multiple copies of an epitope of a plaque-forming polypeptide and methods of using same
AU2003226356A1 (en) 2002-04-12 2003-10-27 Ramot At Tel Aviv University Ltd. Prevention of brain inflammation as a result of induced autoimmune response
GB0720912D0 (en) * 2007-10-25 2007-12-05 Univ Cardiff Monoclonal Anitbody for APP

Similar Documents

Publication Publication Date Title
JP2013181034A5 (enExample)
US10654915B2 (en) Antibodies useful in passive influenza immunization
ES2533493T3 (es) Anticuerpos dirigidos contra la proteína 1 quimioatrayente de monocitos (MCP-1 N1pE) de piroglutamato
JP2018510215A5 (enExample)
JP2012518425A5 (enExample)
US20060034855A1 (en) Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
JP7656627B2 (ja) 変異表面糖タンパク質担体のための免疫化スキーム
KR20110071117A (ko) 변성된 아밀로이드 베타 펩티드
TW202221022A (zh) 用於治療阿茲海默症之tau疫苗
US20200347138A1 (en) Dendritic cells-targeting vaccine
JP2012502663A5 (enExample)
JP2012510802A5 (enExample)
Uppada et al. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice
EP3313435A1 (en) Novel vaccines in prevention and treatment of malaria
JP2012510802A (ja) 完全ヒトインフルエンザm2特異的抗体
RU2017103755A (ru) Вещества и способы для применения при предупреждении и/или лечении болезни гентингтона
US10590178B2 (en) Chimeric vaccine against fungal infections
Axelsen et al. Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42
CN109890839A (zh) 识别sage1抗原短肽的t细胞受体
WO2018085488A1 (en) Universal mammalian influenza vaccine
US20180186896A1 (en) Vaccines for the treatment and prevention of ige mediated diseases
RU2020125383A (ru) ПЕПТИДНЫЕ ИММУНОГЕНЫ И СОДЕРЖАЩИЕ ИХ СОСТАВЫ, НАЦЕЛЕННЫЕ НА МЕМБРАНОСВЯЗАННЫЕ IgE ДЛЯ ЛЕЧЕНИЯ ОПОСРЕДОВАННЫХ IgE АЛЛЕРГИЧЕСКИХ ЗАБОЛЕВАНИЙ
JP2025529904A (ja) Sars-cov-2免疫原性組成物および方法
Solopova et al. Conformational differences between active angiotensins and their inactive precursors
TH2001005860A (th) วัคซีนทางการบำบัดชนิดต้าน a-เบตา